Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.64 USD
−14.12 M USD
7.30 M USD
3.65 M
About Pulmatrix, Inc.
Sector
CEO
Peter B. Ludlum
Headquarters
Framingham
Website
Founded
2003
FIGI
BBG003TH2QL1
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. in April 2003 and is headquartered in Framingham, MA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PULM is 6.04 USD — it has decreased by −1.31% in the past 24 hours. Watch Pulmatrix, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Pulmatrix, Inc. stocks are traded under the ticker PULM.
PULM stock has fallen by −14.93% compared to the previous week, the month change is a 205.05% rise, over the last year Pulmatrix, Inc. has showed a 241.24% increase.
PULM reached its all-time high on Mar 21, 2014 with the price of 4,235.00 USD, and its all-time low was 1.55 USD and was reached on Mar 19, 2024. View more price dynamics on PULM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PULM stock is 9.88% volatile and has beta coefficient of −4.44. Track Pulmatrix, Inc. stock price on the chart and check out the list of the most volatile stocks — is Pulmatrix, Inc. there?
Today Pulmatrix, Inc. has the market capitalization of 22.35 M, it has decreased by −6.86% over the last week.
Yes, you can track Pulmatrix, Inc. financials in yearly and quarterly reports right on TradingView.
Pulmatrix, Inc. is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
PULM net income for the last quarter is −2.59 M USD, while the quarter before that showed −5.81 M USD of net income which accounts for 55.48% change. Track more Pulmatrix, Inc. financial stats to get the full picture.
No, PULM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 26, 2024, the company has 22.00 employees. See our rating of the largest employees — is Pulmatrix, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pulmatrix, Inc. EBITDA is −6.78 M USD, and current EBITDA margin is −181.76%. See more stats in Pulmatrix, Inc. financial statements.
Like other stocks, PULM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pulmatrix, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pulmatrix, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pulmatrix, Inc. stock shows the buy signal. See more of Pulmatrix, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.